Loading...
XSTO
QLINEA
Market cap45mUSD
Jul 09, Last price  
0.07SEK
1D
1.68%
1Q
69.47%
IPO
-99.90%
Name

Q linea AB

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
181.29
EPS
—
Div Yield, %
—
Shrs. gr., 5y
104.94%
Rev. gr., 5y
18.64%
Revenues
2m
-46.80%
81,0001,500,0001,066,0001,005,000243,0009,335,00012,788,0004,440,0002,362,000
Net income
-217m
L-5.45%
-60,091,000-67,879,000-128,353,000-178,060,000-220,191,000-233,183,000-275,770,000-229,366,000-216,871,000
CFO
-182m
L-20.14%
-52,834,000-62,865,000-122,712,000-169,760,000-237,305,000-255,050,000-250,863,000-228,521,000-182,495,000
Earnings
Jul 10, 2025

Profile

Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in Sweden. It offers inventive systems for in vitro diagnostics systems for infectious diseases. The company's lead product candidate is ASTar, an antibiotic susceptibility testing system used for positive blood cultures. It develops and delivers solutions for healthcare providers. Q-linea AB (publ) was incorporated in 2008 and is headquartered in Uppsala, Sweden.
URL
https://www.qlinea.com/
IPO date
Dec 07, 2018
Employees
149
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,362
-46.80%
4,440
-65.28%
12,788
36.99%
Cost of revenue
13,475
131,537
266,831
Unusual Expense (Income)
NOPBT
(11,113)
(127,097)
(254,043)
NOPBT Margin
Operating Taxes
7,076
Tax Rate
NOPAT
(11,113)
(127,097)
(261,119)
Net income
(216,871)
-5.45%
(229,366)
-16.83%
(275,770)
18.26%
Dividends
Dividend yield
Proceeds from repurchase of equity
262,885
BB yield
-107.75%
Debt
Debt current
105,137
7,659
6,117
Long-term debt
57,773
33,469
29,625
Deferred revenue
Other long-term liabilities
(14,814)
Net debt
137,246
(44,862)
(39,922)
Cash flow
Cash from operating activities
(182,495)
(228,521)
(250,863)
CAPEX
(4,991)
(8,341)
(17,249)
Cash from investing activities
(5,043)
(7,766)
315,254
Cash from financing activities
131,273
245,407
(6,604)
FCF
19,591
(157,888)
(274,159)
Balance
Cash
25,664
81,895
72,617
Long term investments
4,095
3,047
Excess cash
25,546
85,768
75,025
Stockholders' equity
(1,511,551)
(1,293,728)
(1,073,342)
Invested Capital
1,635,300
1,503,928
1,241,088
ROIC
ROCE
EV
Common stock shares outstanding
828,098
65,941
29,209
Price
0.69
-81.35%
3.70
-64.76%
10.50
-90.71%
Market cap
571,388
134.19%
243,983
-20.45%
306,699
-90.39%
EV
708,634
199,121
266,781
EBITDA
(11,113)
(109,576)
(238,757)
EV/EBITDA
Interest
3,706
1,569
719
Interest/NOPBT